Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects
NCT04025502 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 161
Last updated 2021-02-24
Summary
This is an observational, non-interventional study that will recruit Healthy Volunteers (HV) and subjects with clinically confirmed Schizophrenia (SZ). The purpose of this study is to establish the mean and variance across the HV and SZ cohorts, sites, and repeated tests of the electroencephalogram(EEG)/Event-related potentials (ERP) measures.
Conditions
Interventions
- DEVICE
-
Event-Related Potentials (ERP) and Electroencephalogram (EEG) testing with the COGNISION® System
The testing protocol consists of an auditory oddball Event-Related Potential (ERP) paradigm, 40Hz ASSR, and the collection of 6 minutes of resting electroencephalogram (EEG). During the ERP paradigm a variety of auditory stimuli are played through the system's earphones while voltage potentials are recorded from the subject's scalp. At the end of the ERP session, 6 minutes of EEG data will be recorded while the subject is resting. The entire procedure, including set up, instructions to the subject and actual test is expected to take 60-75 minutes.
Sponsors & Collaborators
- collaborator INDUSTRY
-
Alkermes, Inc.
collaborator INDUSTRY -
Anavex Life Sciences Corp.
collaborator INDUSTRY - collaborator INDUSTRY
- collaborator INDUSTRY
-
Sage Therapeutics
collaborator INDUSTRY -
H. Lundbeck A/S
collaborator INDUSTRY -
Astellas Pharma Inc
collaborator INDUSTRY -
Apex Innovative Sciences
collaborator UNKNOWN - collaborator OTHER
-
COGNISION
collaborator UNKNOWN -
ERP Biomarker Qualification Consortium
lead INDUSTRY
Principal Investigators
-
Marco Cecchi, PhD · ERP Biomarker Qualification Consortium
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-10-07
- Primary Completion
- 2020-12-29
- Completion
- 2021-01-31
Countries
- United States
Study Locations
More Related Trials
-
Timing of Voluntary Movement in Patients With Schizophrenia
NCT00080548 ·Status: COMPLETED
-
Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia
NCT01545999 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Changes in Brain Synchronization During Perceptual and Linguistic Tasks in Schizophrenic Patients
NCT01550211 ·Status: UNKNOWN
-
CVN058 Effect on Mismatch Negativity in Schizophrenics
NCT03669250 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biomarkers to Enhance Early Schizophrenia Treatment
NCT06969755 ·Status: RECRUITING ·Phase: PHASE4
-
Cognitive Enhancement Therapy for Early-Stage Schizophrenia
NCT00167362 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Remediation in Schizophrenia
NCT01903707 ·Status: UNKNOWN ·Phase: NA
-
The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders
NCT03166098 ·Status: COMPLETED
-
Remediation of Visual Perceptual Impairments in People With Schizophrenia
NCT03314129 ·Status: COMPLETED ·Phase: NA
-
Study of ALTO-101 in Patients With Schizophrenia
NCT06502964 ·Status: RECRUITING ·Phase: PHASE2
-
A Comparison of Two Cognitive Batteries in People With Schizophrenia
NCT00499044 ·Status: COMPLETED ·Phase: NA
-
Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia
NCT00664274 ·Status: UNKNOWN ·Phase: NA
-
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
NCT00207064 ·Status: COMPLETED ·Phase: NA
-
Schizophrenia Cognition Scale Development
NCT02118571 ·Status: COMPLETED
-
Brain Imaging, Attention, and Auditory Processing in Schizophrenia
NCT03068806 ·Status: COMPLETED
-
Neurophysiologic Biomarkers for Cognitive Rehabilitation
NCT05945602 ·Status: RECRUITING
-
Improving Cognition Via Exercise in Schizophrenia
NCT03270098 ·Status: COMPLETED ·Phase: NA
-
Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia
NCT02237235 ·Status: COMPLETED ·Phase: PHASE2
-
Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia
NCT04220099 ·Status: COMPLETED
-
Cognitive Rehabilitation in Schizophrenia
NCT00248794 ·Status: COMPLETED ·Phase: NA
-
Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
NCT03790085 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Biomarkers in First Episode Schizophrenia
NCT02033382 ·Status: COMPLETED
-
Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder
NCT04278339 ·Status: RECRUITING ·Phase: NA
-
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
NCT00567099 ·Status: UNKNOWN ·Phase: NA